-
A December 2013 court order demanding that manufacturer Abbott Laboratories provide “long overdue” documents for Depakote is being viewed as a success for plaintiffs. The court order, made in the US District Court for the Southern
-
The Chicago Tribune had an interesting story last month about prescription contraceptives and their link to blood clots. According to the Tribune, Maggie Yunker suffered a stroke after multiple blood clots formed in her body and lodged in
-
Do you or a loved one take blood pressure medication? If so, you should be aware of the latest FDA Recall Announcements for certain blood pressure drugs that contain valsartan, irbesartan and losartan. These popular
-
Zoll & Kranz, LLC is stepping up its investigation into congenital birth defects, including heart defects, cleft palate, and cleft lip injuries caused by Zofran. Zofran, also known generically as Ondansetron, was developed by GlaxoSmithKline
-
Attorney General Eric T. Schneiderman of New York recently asked GNC, Target, Walgreens, and Walmart to stop sales of certain store brand herbal supplements due to the failure of DNA testing on the detection of
-
The Synchromed II Implantable Infusion Pump System, manufactured by Medtronic, Inc, is a pump which infuses pain medication, Baclofen, through a catheter into a patient’s spine. This medical device is used to treat primary or
-
The law firm of Zoll & Kranz, LLC has filed another lawsuit on behalf of two more people alleged to be wrongly diagnosed with Alzheimer’s disease and depressive pseudodementia. Today, September 12, 2016, the Complaint
-
Since the 1970s, Monsanto’s Roundup has been one of the most-used herbicides in the United States. Roundup’s active ingredient is a compound called glyphosate, which is mainly used by agricultural workers to kill weeds that
-
The product liability attorneys at Zoll & Kranz, LLC have reason to believe the U.S. consumer market will be notified in the near future about a safety notice or recall from medical device manufacturer Stryker
-
A multidistrict litigation (MDL) has been created for lawsuits alleging permanent hair loss resulting from use of the chemotherapy drug Taxotere. On October 4, 2016, the United States Judicial Panel on Multidistrict Litigation (JPML) granted